Skip to main content

Table 3 Assessment of malaria service delivery

From: An assessment of the knowledge, practices and resources during the delivery of malaria health care services among private health care practitioners: a cross section study in the Mid-Western Region of Uganda

Assessment area Number
N = 135
Percentage (95% CI)
Malaria treatment policy and guidelines
 Availability of malaria treatment protocols/guidelines 95 70.37(62.02 - 77.54)
 Access to malaria treatment protocols/guidelines 90 66.67(58.19 - 74.18)
 Use of malaria treatment protocols/guidelines 83 61.48(52.91 - 69.40)
 Heard of malaria test and treat policy 91 67.41(58.96 - 74.86)
Source of malaria information
 Ministry of Health 71 52.49(43.82 - 61.25)
 District health team 9 6.67(3.09 - 12.28)
 Media 36 26.67(19.43 - 34.59)
 Colleagues 35 25.93(18.77 - 34.17)
 Information obtained during formal education 36 26.67(19.43 - 34.96)
 Others (seminars and workshops) 4 2.96(0.81 - 7.41)
Staff training and mentorship
 Respondent received malaria related training in the last 12 months 66 48.89(40.19 - 57.63)
 Training on malaria treatment protocols/guidelines 55 40.74(32.37 - 49.53)
Staff knowledge
 Correct malaria definition 112 82.96(75.54 - 88.88)
 Correct definition of uncomplicated malaria 54 40.00(31.67 - 48.79)
 Correct definition of complicated/severe malaria 115 85.19(78.05 - 90.71)
Malaria laboratory practices
 Presence of malaria laboratory services 133 98.52(94.75 - 99.82)
 Availability of adequate space for laboratory 102 75.56(67.42 - 82.54)
 Presence of skilled laboratory personnel 78 57.78(48.98 - 66.22)
 Training of laboratory staff on malaria testing 54 40.00(31.67 - 48.79)
 Availability of malaria laboratory testing protocols
  Available and seen 53 39.26(30.97 - 48.03)
  Available and not seen 22 16.30(10.50 - 23.63)
  Not available 60 44.44(35.90 - 53.24)
 Types of malaria tests used
  Microscopy 12 8.89(4.68 - 15.01)
  Malaria RDTs 52 38.52(30.28 - 47.28)
  Both 71 52.59(43.82 - 61.25)
Anti malaria drugs stock at facility
 Anti-malaria drugs available in stock at the facility, on day of assessment
  Artemether-Lumefantrine tablets 15 85.19(78.05 - 90.71)
  Quinine (either tablets or injections) 101 74.81(66.62 – 81.89)
  Artesunate (intravenous) 98 72.59(64.25 – 79.91)
  Sulphadoxine – Pyrimethanine (SP) tablets 34 25.19(18.11 – 33.38)
  Dihydro –artemesinin piperaquine tablets 21 15.56(9.89 – 22.79)
  Chloroquine tablets 4 2.96(1.00 – 7.41)